✦
UWELL CLOUD YOU JIAN YUN

Drugs & Devices

Azvudine

azvudine

Ask on WhatsApp

Primary source: China · NMPA approval announcement · Source publication:
Source checked:

Azvudine · Molecular structure from PubChem; not a product photograph.
Molecular structure from PubChem; not a product photograph.
PubChem CID 24769759

Clinical source excerpts are in English. Review the original label with your clinician.

What is it used for?

Azvudine is a nucleoside reverse-transcriptase inhibitor. The cited 2021 Chinese announcement describes conditional approval for adults with HIV-1 infection, combined with other antiretroviral medicines. This historical announcement does not establish a current indication for another infection.

Read the primary source

This source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.

Product details

Active ingredient
azvudine
Form and strength
Oral tablets; the exact marketed strength must be confirmed from the current Chinese label.
Manufacturer / applicant
Genuine Biotech

Oral tablets; the exact marketed strength must be confirmed from the current Chinese label.

Safety and clinical review

A current full prescribing document is needed to assess contraindications, interactions and monitoring. This page does not recommend treatment or establish eligibility.

  • Current Chinese prescribing information
  • Combination antiretroviral regimen
  • Interaction and monitoring review

Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.

Read the primary source

Prepare your enquiry

Include the brand or generic name, strength, dosage form, requested quantity and country where care is needed. You can attach a prescription when you continue.

Questions patients ask

What is Azvudine used for?

Azvudine is a nucleoside reverse-transcriptase inhibitor. The cited 2021 Chinese announcement describes conditional approval for adults with HIV-1 infection, combined with other antiretroviral medicines. This historical announcement does not establish a current indication for another infection.

This source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.

Which formulation of Azvudine should I ask about?

Oral tablets; the exact marketed strength must be confirmed from the current Chinese label.

Read the primary source
What determines the price of Azvudine?

A current quote depends on the exact presentation, quantity, provider and access arrangements. A catalogue entry is not a stock or delivery promise. Medical charges are paid to the provider, separately from coordination fees.

What should I check before using Azvudine?

Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.

Sources and review scope

Read the primary source

China · NMPA approval announcement — AZVUDINE

Primary source: China · NMPA approval announcement · Source publication:
Source checked:

This source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.

More catalogue entries

Sariyah Ahmad
Active Triage Officer

Welcome to Uwell Cloud. Connecting from Malaysia, Indonesia, or Thailand? Ask me about visa-free travel and stem cell medical programs in Boao Lecheng.